Joseph Y Ting1, Vicki Sk Goh1, Horacio Osiovich1. 1. Division of Neonatology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia.
Abstract
BACKGROUND: The use of central venous catheters has permitted lifesaving treatment for critically ill neonates; however, the attributable mortality rate for central line-associated bloodstream infections (CLABSIs) has been estimated to be between 4% and 20%. In 2006/2007, the authors' neonatal intensive care unit (NICU) had a CLABSI rate that was nearly twofold higher than that reported by other Canadian NICUs. OBJECTIVE: To implement a quality improvement collaborative to reduce the incidence of neonatal CLABSI. METHODS: A retrospective observational study was performed to compare CLABSI in neonates admitted to the authors' level III NICU between August 2007 and March 2011. The entire study period was divided into four time periods to evaluate secular trends. A comprehensive catheter-related bloodstream infection prevention initiative was implemented in August 2007. The initiatives included staff education, standardization of skin preparation protocol, introduction of new antiseptic agents, implementation of central catheter insertion and maintenance checklists, reinforcement of the use of maximal sterile barrier precautions, and revision of the central catheter configuration and maintenance protocols. RESULTS: The median CLABSI rate of 7.9 per 1000 catheter days at the beginning of the study (period 1 [August 2007 to June 2008]) gradually decreased over the entire study period (P=0.034): period 2 (July 2008 to May 2009), 3.3 per 1000 catheter days; period 3 (June 2009 to April 2010), 2.6 per 1000 catheter days; and period 4 (May 2010 to March 2011), 2.2 per 1000 catheter days. CONCLUSION: A multidisciplinary evidence-based quality improvement collaborative resulted in a significant reduction in the CLABSI rate. Continuous quality improvement measures are required to reduce catheter-related bloodstream infections among low-birth-weight infants.
BACKGROUND: The use of central venous catheters has permitted lifesaving treatment for critically ill neonates; however, the attributable mortality rate for central line-associated bloodstream infections (CLABSIs) has been estimated to be between 4% and 20%. In 2006/2007, the authors' neonatal intensive care unit (NICU) had a CLABSI rate that was nearly twofold higher than that reported by other Canadian NICUs. OBJECTIVE: To implement a quality improvement collaborative to reduce the incidence of neonatal CLABSI. METHODS: A retrospective observational study was performed to compare CLABSI in neonates admitted to the authors' level III NICU between August 2007 and March 2011. The entire study period was divided into four time periods to evaluate secular trends. A comprehensive catheter-related bloodstream infection prevention initiative was implemented in August 2007. The initiatives included staff education, standardization of skin preparation protocol, introduction of new antiseptic agents, implementation of central catheter insertion and maintenance checklists, reinforcement of the use of maximal sterile barrier precautions, and revision of the central catheter configuration and maintenance protocols. RESULTS: The median CLABSI rate of 7.9 per 1000 catheter days at the beginning of the study (period 1 [August 2007 to June 2008]) gradually decreased over the entire study period (P=0.034): period 2 (July 2008 to May 2009), 3.3 per 1000 catheter days; period 3 (June 2009 to April 2010), 2.6 per 1000 catheter days; and period 4 (May 2010 to March 2011), 2.2 per 1000 catheter days. CONCLUSION: A multidisciplinary evidence-based quality improvement collaborative resulted in a significant reduction in the CLABSI rate. Continuous quality improvement measures are required to reduce catheter-related bloodstream infections among low-birth-weight infants.
Entities:
Keywords:
Bloodstream infection; Central line; Neonate
Authors: Donna Holton; Shirley Paton; John Conly; Joanne Embree; Geoffrey Taylor; William Thompson Journal: Can J Infect Dis Med Microbiol Date: 2006-05 Impact factor: 2.471
Authors: D D Wirtschafter; J Pettit; P Kurtin; M Dalsey; K Chance; H W Morrow; M Seid; T L Byczkowski; T P Huber; J M Milstein; S M Bowles; S Fichera; S Kloman Journal: J Perinatol Date: 2009-11-26 Impact factor: 2.521
Authors: Naomi P O'Grady; Mary Alexander; Lillian A Burns; E Patchen Dellinger; Jeffrey Garland; Stephen O Heard; Pamela A Lipsett; Henry Masur; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne G Randolph; Mark E Rupp; Sanjay Saint Journal: Am J Infect Control Date: 2011-05 Impact factor: 2.918
Authors: Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein Journal: MMWR Recomm Rep Date: 2002-08-09
Authors: I I Raad; D C Hohn; B J Gilbreath; N Suleiman; L A Hill; P A Bruso; K Marts; P F Mansfield; G P Bodey Journal: Infect Control Hosp Epidemiol Date: 1994-04 Impact factor: 3.254
Authors: A J Vachharajani; N A Vachharajani; H Morris; A Niesen; A Elward; D A Linck; A M Mathur Journal: J Perinatol Date: 2017-01-12 Impact factor: 2.521
Authors: Jennifer Zeitlin; Bradley N Manktelow; Aurelie Piedvache; Marina Cuttini; Elaine Boyle; Arno van Heijst; Janusz Gadzinowski; Patrick Van Reempts; Lene Huusom; Tom Weber; Stephan Schmidt; Henrique Barros; Dominico Dillalo; Liis Toome; Mikael Norman; Beatrice Blondel; Mercedes Bonet; Elisabeth S Draper; Rolf F Maier Journal: BMJ Date: 2016-07-05
Authors: Gerdina H Dubbink-Verheij; Vincent Bekker; Iris C M Pelsma; Erik W van Zwet; Vivianne E H J Smits-Wintjens; Sylke J Steggerda; Arjan B Te Pas; Enrico Lopriore Journal: Front Pediatr Date: 2017-06-20 Impact factor: 3.418